Moreover, higher serum APEX1 level was associated with lymph node metastasis and shorter survival time of the patients, so serum APEX1 level might also be a potential biomarker for poor prognosis of CCA. This evidence concerns the gene APEX1 and metastatic malignant neoplasm in the lymph nodes.